Search research articles
Contact Us
Filters
Showing results (201-210 of 239) with videos related to
Page
of 24
Sort By:
Journal of Endocrinological Investigation
|
August 9, 2003
Lipoprotein (a) in childhood: correlations with family history of cardiovascular disease
M De Simone, A Verrotti, M Cappa, et al.
Acta Neurologica Scandinavica
|
November 17, 2010
Valproic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet
G Coppola, A Verrotti, A D'Aniello, et al.
International Journal of Immunopathology and Pharmacology
|
June 16, 2012
Acquired peripheral neuropathy: a report on 20 children
P Pavone, A D Praticò, M Ruggieri, et al.
Diabetes Care
|
November 5, 1998
Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy
L Lobefalo, A Verrotti, L Mastropasqua, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 29, 2000
Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications
F Chiarelli, A Spagnoli, F Basciani, et al.
Seizure
|
January 6, 2007
Levetiracetam monotherapy for children and adolescents with benign rolandic seizures
A Verrotti, G Coppola, R Manco, et al.
AIDS (London, England)
|
April 19, 2000
Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein
P Pelliccia, L Galli, M de Martino, et al.
International Journal of Immunopathology and Pharmacology
|
January 10, 2013
Primary headaches in children: clinical findings on the association with other conditions
P Pavone, R Rizzo, I Conti, et al.
International Journal of Immunopathology and Pharmacology
|
February 13, 2003
Skin reactions due to anti-epileptic drugs: several case-reports with long-term follow-up
C Feliciani, A Verrotti, G Coscione, et al.
Acta Neurologica Scandinavica
|
June 29, 2011
Effects of the abrupt switch from solution to modified-release granule formulation of valproate
A Verrotti, G Nanni, S Agostinelli, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 239) with videos related to
Sort By:
Page
of 24
Journal of Endocrinological Investigation
|
August 9, 2003
Lipoprotein (a) in childhood: correlations with family history of cardiovascular disease
M De Simone, A Verrotti, M Cappa, et al.
Acta Neurologica Scandinavica
|
November 17, 2010
Valproic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet
G Coppola, A Verrotti, A D'Aniello, et al.
International Journal of Immunopathology and Pharmacology
|
June 16, 2012
Acquired peripheral neuropathy: a report on 20 children
P Pavone, A D Praticò, M Ruggieri, et al.
Diabetes Care
|
November 5, 1998
Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy
L Lobefalo, A Verrotti, L Mastropasqua, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 29, 2000
Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications
F Chiarelli, A Spagnoli, F Basciani, et al.
Seizure
|
January 6, 2007
Levetiracetam monotherapy for children and adolescents with benign rolandic seizures
A Verrotti, G Coppola, R Manco, et al.
AIDS (London, England)
|
April 19, 2000
Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein
P Pelliccia, L Galli, M de Martino, et al.
International Journal of Immunopathology and Pharmacology
|
January 10, 2013
Primary headaches in children: clinical findings on the association with other conditions
P Pavone, R Rizzo, I Conti, et al.
International Journal of Immunopathology and Pharmacology
|
February 13, 2003
Skin reactions due to anti-epileptic drugs: several case-reports with long-term follow-up
C Feliciani, A Verrotti, G Coscione, et al.
Acta Neurologica Scandinavica
|
June 29, 2011
Effects of the abrupt switch from solution to modified-release granule formulation of valproate
A Verrotti, G Nanni, S Agostinelli, et al.
Page
of 24